Clinical Supply–Why Putting Patients First Matters
The time to stop hammering square pegs into round holes in terms of design strategy has come, as sponsors embrace an adaptive supply chain approach.
The growing volume of clinical studies and the increasing ‘need for speed’ is symptomatic of a highly competitive biopharmaceutical marketplace. When coupled with the emergence of biologics,predicted to grow at a CAGR of 9.7 percent between 2016 and 20211, it becomes apparent that over the last decade drug development has evolved and will continue to do so.
Read more on this article by clicking here.View Resource
Almac Clinical Services
Guided by our extensive clinical supply experience and expertise, Almac Clinical Services is recognised as an innovative, global solution provider within the specialised and complex market of clinical trial supply.
Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.
Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.